# Pfizer Requests FDA Vaccine Authorization for Children 5 to 11

By Human Events · Published 2021-10-07 · News & Analysis › Faith & Family · https://humanevents.com/news/pfizer-requests-fda-vaccine-authorization-for-children-5-to-11

> Pfizer asked the FDA Thursday to authorize emergency use of the COVID-19 vaccine for children ages 5 to 11. The company says they are submitting data supporting the change to the FDA, which has promised to move quickly on the request and has tentatively scheduled a meeting on October 26 to consider it, the New \[…\]

Pfizer asked the FDA Thursday to authorize emergency use of the COVID-19 vaccine for children ages 5 to 11.

The company says they are submitting data supporting the change to the FDA, which has promised to move quickly on the request and has tentatively scheduled a meeting on October 26 to consider it, the *New York Times* [reports.](https://www.nytimes.com/2021/10/07/us/politics/pfizer-fda-authorization-children-5-11.html?campaign_id=60&emc=edit_na_20211007&instance_id=0&nl=breaking-news&ref=cta&regi_id=94350836&segment_id=70901&user_id=d0df33b2e0eda809063303c7c5cb8cdf)

“With new cases in children in the U.S. continuing to be at a high level, this submission is an important step in our ongoing effort against Covid-19,” Pfizer said Thursday.

Authorization depends on the strength of the clinical trial data, as well as whether the company can prove they are able to properly manufacture a new pediatric formula.

Pfizer has proposed giving children one-third of the dose adults receive, which might require adding more diluent to each injection or using a different syringe.

Pfizer’s clinical trial for children looked at antibody levels, comparing them with adult levels. Indeed, the trial included 2,268 children. Two-thirds of them received two doses of the vaccine three weeks apart, while the remaining were injected with a saltwater placebo.

Regulators are expected to compare the responses between children and adults.